Session Recordings
Current State of Play: PrEP Implementation Update and Challenges
HIV R4P 2018 Satellite | Madrid, Spain | October 22, 2018
This session provided participants with an update on where we are with PrEP and future products, current understanding of the different approaches to oral PrEP implementation in low- and middle-income countries, and the challenges faced and solutions found in efforts to scale up programs. Panel discussions elicited perspectives from key experts and included debate on current controversies over considering and prioritizing PrEP implementation.
Hosted by: ICAP at Columbia University, World Health Organization (WHO), AVAC, CHAI, and HIV Prevention Trials Network (HPTN)
Welcome Remarks
Wafaa El-Sadr, ICAP at Columbia University
Emily Donaldson, AVAC
Session 1: Global Update
State of Oral PrEP Implementation and Scale-up
Michelle Rodolph, WHO
Q&A
Session 2: PrEP Implementation – Key Issues and Controversies
Moderator: Wafaa El-Sadr
PrEP for Adolescent Girls and Young Women
Nelly Mugo, KEMRI
Efficacy of TDF-FTC PrEP in women?
Mike Cohen, UNC – Chapel Hill
PrEP Persistence: Challenges and Opportunities
Susan Buchbinder, UCSF
Demedicalizing PrEP
Sheena McCormack, MRC
Session 3: Lessons Learned in Implementing & Scaling-up oral PrEP
Moderator: Mitchell Warren
Lessons from South Africa
Hasina Sudebar, National Department of Health, South Africa
Lessons from Kenya
Daniel Were, Jhpiego Kenya
Lessons from Brazil
Beatriz Grinszteijn, INI, Brazil
Lessons from the United States
John Brooks, US CDC
Lessons from Ukraine
Olga Denisiuk, Alliance for Public Health, Ukraine
Session 4: Looking Ahead
Next Generation of PrEP
Nyaradzo Mgodi, University of Zimbabwe College of Health Sciences Clinical Trials Research Centre
Closing Remarks
Wafaa El-Sadr, ICAP at Columbia University
Emily Donaldson, AVAC
